Tissutal immune profile and pathological complete response in triple negative breast cancer

被引：0
|
作者：
Botticelli, Andrea [1 ]
Cerbelli, Bruna [1 ]
Scagnoli, Simone [1 ]
Amabile, Maria Ida [1 ]
De Luca, Alessandro [1 ]
Fortunato, Lucio [2 ]
Costarelli, Leopoldo [2 ]
Nuti, Marianna [1 ]
D'Amati, Giulia [1 ]
Marchetti, Paolo [1 ]
机构：
[1] Sapienza Univ Rome, Rome, Italy
[2] San Giovanni Addolorata Hosp, Rome, Italy
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P114
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Additional biomarkers for pathological complete response in triple negative breast cancer
    Weem, Khui Wei
    Tong, Kah Cheong
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
  • [2] Pathological complete response with chemotherapy and immune checkpoint inhibition in triple negative inflammatory breast cancer (TN-IBC)
    Lynce, Filipa
    Niman, Samuel
    Goncalves, Anthony
    Kai, Megumi
    Ryan, Sean
    Troll, Elizabeth
    Layman, Rachel
    Giordano, Antonio
    Nasrazadani, Azadeh
    Nakhlis, Faina
    Bellon, Jennifer
    Warren, Laura
    Block, Caroline
    Schumer, Susan
    Lucci, Anthony
    Krishnamurthy, Savitri
    Lerebours, Florence
    Dalenc, Florence
    Levy, Christelle
    Petit, Thierry
    Leheurteur, Marianne
    Bachelot, Thomas
    Tredan, Olivier
    Ladoire, Sylvain
    Almeida, Leonor Lopez
    Zemmour, Christophe
    Tolaney, Sara
    Valero, Vicente
    Bertucci, Francois
    Regan, Meredith
    Woodward, Wendy
    CANCER RESEARCH, 2024, 84 (09)
  • [3] Pathological complete response to neoadjuvant chemotherapy in triple negative breast cancer – single hospital experience
    Elina Sivina
    Lubova Blumberga
    Gunta Purkalne
    Arvids Irmejs
    Hereditary Cancer in Clinical Practice, 21
  • [4] Clinical predictors of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer
    Nakashoji, Ayako
    Matsui, Akira
    Nagayama, Aiko
    Iwata, Yuko
    Sasahara, Manami
    Murata, Yuya
    ONCOLOGY LETTERS, 2017, 14 (04) : 4135 - 4141
  • [5] Predictive markers of complete pathological response to neoadjuvant chemoimmunotherapy in triple negative breast cancer.
    Cankar, Kaja
    Auprih, Masa
    Ovcaricek, Tanja
    Kovac, Anja
    Sarvari, Natasa Snoj
    Dobovisek, Luka
    Borstnar, Simona
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] Pathological complete response to neoadjuvant chemotherapy in triple negative breast cancer - single hospital experience
    Sivina, Elina
    Blumberga, Lubova
    Purkalne, Gunta
    Irmejs, Arvids
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2023, 21 (01)
  • [7] A preliminary study on predicting pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer
    Chen, Xi
    Zhou, Zhiguo
    CANCER RESEARCH, 2024, 84 (03)
  • [8] Pathological complete response is associated with excellent outcomes in BRCA mutation associated triple negative breast cancer
    Prochaska, L. H.
    Godwin, A. K.
    Kimler, B. F.
    Lehn, C.
    Klemp, J. R.
    O'Dea, A.
    Elia, M.
    Hoffmann, M. S.
    Crane, G.
    McKittrick, R.
    Sheehan, M.
    Graff, S. L.
    Madhusudhana, S.
    Khan, Q. J.
    Jensen, R. A.
    Sharma, P.
    CANCER RESEARCH, 2017, 77
  • [9] Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
    Gass, Paul
    Lux, Michael P.
    Rauh, Claudia
    Hein, Alexander
    Bani, Mayada R.
    Fiessler, Cornelia
    Hartmann, Arndt
    Haeberle, Lothar
    Pretscher, Jutta
    Erber, Ramona
    Wachter, David L.
    Schulz-Wendtland, Ruediger
    Beckmann, Matthias W.
    Fasching, Peter A.
    Wunderle, Marius
    BMC CANCER, 2018, 18
  • [10] Additional biomarkers for pathological complete response in triple negative breast cancer (vol 16, 17588359241267148, 2024)
    Wee, K. W.
    Tong, K. C.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
12345